Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
stock ticker
|
| gptkbp:businessModel |
gptkb:public_company
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
gene therapy
natural killer (NK) cell therapies |
| gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
NKTX
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:refersTo |
gptkb:Nkarta,_Inc.
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:website |
https://nkartatx.com
|
| gptkbp:bfsParent |
gptkb:Nkarta_Therapeutics
|
| gptkbp:bfsLayer |
7
|